<DOC>
	<DOCNO>NCT01860183</DOCNO>
	<brief_summary>Development chronic change ( scar ) transplant kidney tissue major cause long-term kidney function deterioration ultimately graft loss . It result immunologic non-immunologic mechanism . Mycophenolate mofetil ( MMF ) immunosuppressive drug use prevention rejection kidney transplant , usually combination calcineurin inhibitor ( tacrolimus cyclosporine ) , without corticosteroid . Besides immunosuppression , MMF may also direct antifibrotic property . Tacrolimus potent immunosuppressive effect cornerstone contemporary posttransplant immunosuppressive therapy kidney recipient . However , also nephrotoxic . The hypothesis present study set similar net immunosuppression , high dose MMF ( 3 g daily ) result slow progression kidney fibrosis first year posttransplant compare MMF 2 g daily . To test hypothesis , present study randomly assign low immunological risk kidney transplant recipient either 2g 3 g MMF daily , combination tacrolimus , , without maintenance steroid . All patient kidney biopsy implantation 12 month transplantation . Main outcome 1-year change chronic kidney histology ( interstitial fibrosis ) assess protocol biopsy .</brief_summary>
	<brief_title>Effect 3g Versus 2 g MMF Combination With Tacrolimus Progression Renal Allograft Interstitial Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>1. first kidney kidneypancreas transplantation 2 . CDC PRA &lt; =20 % 1. dual kidney transplantation 2 . AB0 incompatible transplantation 3 . 0 biopsy ci , ct , cv , ah score &gt; =2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>kidney transplantation</keyword>
	<keyword>chronic allograft dysfunction</keyword>
	<keyword>mycophenolate mofetil</keyword>
	<keyword>Chronic</keyword>
</DOC>